U.K. COVID-19 Immunity Passports Enter Trial Phases

by Sam Gazeley | 1Q 2021 | IN-6058
It was announced in January 2021 that the United Kingdom had pushed a COVID-19 immunity and vaccination passport into live testing. The passport, developed by deep-tech solutions provider Mvine and facial biometric authentication company iProov with backing from Innovate UK, will display the citizen’s registered vaccination status without the need for their identity to be disclosed. The prototype credential will now go into testing within the National Health Service (NHS) with the aim of completing two successful trials by the end of March 2021. This will be required to establish trust in the digital credential, which is needed to enable its deployment at scale in local areas.

You must be a subscriber to view this ABI Insight.

To find out more about subscribing contact a representative about purchasing options.

Service